Phase 3 Smoking Cessation Clinical Trials
8 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–8 of 8 trials
Recruiting
Phase 3
Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment
Smoking Cessation
University of Kansas Medical Center500 enrolled1 locationNCT05732272
Recruiting
Phase 3
Tobacco Education and Lung Health Study (TEAL)
Smoking Cessation
Georgetown University1,188 enrolled1 locationNCT06290869
Recruiting
Phase 2Phase 3
Evaluating Smoking Cessation Interventions for PWH in South Africa
Comorbidities and Coexisting ConditionsSmoking CessationHIV
Johns Hopkins University660 enrolled1 locationNCT05413122
Recruiting
Phase 3
V+PSF-M for Tobacco Cessation in HIV Care in India
Smoking CessationSmoking, TobaccoHuman Immunodeficiency Virus
University of Colorado, Denver400 enrolled2 locationsNCT05786547
Completed
Phase 3Phase 4
ASCEND: A Study of Cessation using Electronic Nicotine Devices
Smoking Cessation
Health Research Council NZ653 enrolled1 locationACTRN12610000866000
Completed
Phase 3
CASCAID Study: Cytisine as a smoking cessation aid
Smoking Cessation
Health Research Council NZ1,310 enrolled1 locationACTRN12610000590066
Completed
Phase 3
Randomised controlled trial of Zonnic and nicotine patch (ZAP) in smoking cessation
Smoking Cessation
Health Research Council of New Zealand1,600 enrolled1 locationACTRN12609000482268
Completed
Phase 3Phase 4
RELIQ Study: Reduced levels of nicotine in cigarettes to increase quitting
Smoking Cessation
Heath Research Council NZ1,410 enrolled1 locationACTRN12608000410358